Profil
Benjamin Winograd worked as an Executive Director-Clinical Oncology at Bristol Myers Squibb Co. from 1990 to 1999.
He then worked as Vice President-Global Medical Affairs & Oncology at Schering-Plough Biopharma from 2004 to 2007.
From 2007 to 2020, he worked at Celgene Corp.
as Head-Clinical R&D Therapeutic Area.
Currently, he is the Chief Medical Officer at LAVA Therapeutics NV, a position he started in 2020 and will hold until 2023.
Dr. Winograd received his graduate and doctorate degrees from Technische Universität München.
Tidigare kända positioner av Benjamin Winograd
| Företag | Position | Slut |
|---|---|---|
| LAVA THERAPEUTICS | Teknisk/Vetenskaplig/F&U Direktör | 2023-02-06 |
| CELGENE | Företagsledare/Principal | 2020-01-01 |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services | Företagsledare/Principal | 2007-01-01 |
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | 1999-01-01 |
Benjamin Winograds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services | Commercial Services |
LAVA Therapeutics NV
LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
















